Nebula Research & Development LLC Castle Biosciences Inc Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 37,617 shares of CSTL stock, worth $605,633. This represents 0.07% of its overall portfolio holdings.
Number of Shares
37,617
Previous 26,674
41.02%
Holding current value
$605,633
Previous $711 Million
5.94%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.7MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$49 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$33 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$23.6 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.4 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $423M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...